Select Your Region
Global
Search results
Review the results we have found for you.
Use the filters to narrow down the results list and easily find the trial you look for.
Refine your search
Search
Parkinson's Disease (PD)
Location
Please note that the recruitment status of the study at your site may differ from the overall study status because some study sites may recruit earlier than others.
We could not find any results for 'PARKINSON'S DISEASE (PD)'. Below you can find all 69 available trials.
Change search criteria or use the filters to narrow down your search.
1 
Study StatusActive, not recruiting1 A clinical trial to compare glofitamab plus chemotherapy with rituximab plus chemotherapy in people with diffuse large B-cell lymphoma (after previous treatment has not worked).
A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Cancer,
- Non Hodgkin Lymphoma (NHL),
- Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04408638, GO41944, 2020-001021-31, 2023-506899-27-00
2 Study StatusActive, not recruiting2 A Study Comparing Alectinib With Crizotinib in Treatment-Naive Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer Participants
- Cancer,
- Lung Cancer,
- Non-Small Cell Lung Cancer (NSCLC),
- Non Small Cell Lung Carcinoma
- NCT02075840, BO28984, 2013-004133-33
3 Study StatusActive, not recruiting3 A study to evaluate the efficacy and safety of fenebrutinib compared with teriflunomide in adult patients with relapsing multiple sclerosis (FENhance 1)
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
- Autoimmune Disorder,
- Multiple Sclerosis (MS),
- Neurodegenerative Disorder,
- Relapsing Multiple Sclerosis (RMS)
- NCT04586010, GN41851, 2019-004857-10,2022-502609-14-00
4 Study StatusActive, not recruiting4 A rollover study to evaluate the long-term safety and efficacy of ocrelizumab in patients with multiple sclerosis
A Rollover Study to Evaluate the Long-Term Safety and Efficacy of Ocrelizumab In Patients With Multiple Sclerosis
- Autoimmune Disorder,
- Multiple Sclerosis (MS)
- NCT05269004, MN43964, 2023-505974-14-00
5 Study StatusActive, not recruiting5 A clinical trial to compare glofitamab plus Pola-R-CHP with Pola-R-CHP alone in people with untreated large B-cell lymphoma
An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma
- Cancer,
- Non Hodgkin Lymphoma (NHL),
- Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT06047080, GO44145
6 Study StatusActive, not recruiting6 A study to compare atezolizumab plus lenvatinib or sorafenib with lenvatinib or sorafenib alone in people with advanced and/or inoperable liver cancer (hepatocellular carcinoma) after previous treatment with atezolizumab plus bevacizumab
A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab
- Cancer,
- Hepatocellular Carcinoma (HCC),
- Unresectable Hepatocellular Carcinoma
- NCT04770896, MO42541, 2023-503229-21-00
7 Study StatusActive, not recruiting7 A clinical study to compare obinutuzumab in combination with venetoclax and obinutuzumab in combination with chlorambucil in people with previously untreated chronic lymphocytic leukaemia who have other medical conditions
A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic Leukemia
- Cancer,
- Leukemia,
- Chronic Lymphocytic Leukemia
- NCT02242942, BO25323, 2014-001810-24
8 
Study StatusCompleted8 A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease
- Neurodegenerative Disorder,
- Alzheimer's Disease (AD)
- NCT01224106, WN25203, 2010-019895-66
9 Study StatusCompleted9 A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- Cancer,
- Breast Cancer,
- Breast Cancer HER-2 Positive,
- Breast Neoplasms
- NCT01566721, MO28048, 2011-005328-17
10 Study StatusCompleted10 A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
- Cancer,
- Gastric Cancer
- NCT01774786, BO25114, 2012-003554-83